default author photo

Iván Bravo

Universidad de Castilla-La Mancha

SCHOLARLY PAPERS

5

DOWNLOADS

199

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Tuna Collagen-Based Hydrogels for the Targeted Delivery of Bet Inhibitors and Bet-Protacs in Breast Cancer Therapy

Number of pages: 30 Posted: 08 Jul 2025
Irene Sevilla-Carrillo, Carolina Hermida-Merino, Inmaculada Posadas, Martin Kreuzer, María del Mar Noblejas-López, Alberto Ocaña, Jesús Valcarcel, Daniel Hermida Merino, Manuel M. Piñeiro, Carlos Alonso-Moreno and Iván Bravo
Universidad de Castilla-La Mancha, Universidad Politecnica de Madrid, Universidad de Castilla-La Mancha, ALBA Synchrotron, Universidad de Castilla-La Mancha, affiliation not provided to SSRN, University of Kiel - Institute of Marine Research, University of Vigo, University of Vigo, Universidad de Castilla-La Mancha and Universidad de Castilla-La Mancha
Downloads 43 (1,145,425)

Abstract:

Loading...

Breast cancer, Targeted Protein Degradation, MZ1 PROTAC, JQ1 BET-I, Tuna gelatin hydrogel formulation

2.

Evaluation of Heteroscorpionate Ligands as Scaffolds for the Generation of Ruthenium(Ii) Metallodrugs in Breast Cancer Therapy

Number of pages: 30 Posted: 29 Sep 2023
Elena Domínguez-Jurado, Consuelo Ripoll, Agustín Lara-Sánchez, Alberto Ocaña, Iñigo J. Vitórica-Yrezábal, Iván Bravo and Carlos Alonso-Moreno
Universidad de Castilla-La Mancha, Universidad de Castilla-La Mancha, Universidad de Castilla-La Mancha, Hospital Clínico San Carlos-IdISSC, University of Granada, Universidad de Castilla-La Mancha and Universidad de Castilla-La Mancha
Downloads 43 (1,145,425)

Abstract:

Loading...

heteroscorpionate ligands, Triple negative breast cancer, UNICAM-1, RAPTA-C, therapeutic agents screening, preclinical studies

3.

Combinatorial Biomaterial Design Enables Synchronized BET–PARP Inhibition through Controlled Dual-Drug Delivery in Triple-Negative Breast Cancer

Number of pages: 34 Posted: 15 Apr 2026
Cristina Blasco-Navarro, María del Mar Noblejas-López, Felipe de la Cruz-Martínez, Abdessamad Gueddari, Alberto Ocaña, Agustín Lara-Sánchez, Iván Bravo and Carlos Alonso-Moreno
affiliation not provided to SSRN, Universidad de Castilla-La Mancha, Universidad de Castilla-La Mancha, University of Castilla-La Mancha, Hospital Clínico San Carlos-IdISSC, Universidad de Castilla-La Mancha, Universidad de Castilla-La Mancha and Universidad de Castilla-La Mancha
Downloads 40 (1,290,922)

Abstract:

Loading...

Nanomedicine, Triple-Negative Breast Cancer, BRCA-mutated tumors, PARP inhibitor, BET inhibitor, Combination Therapy, Drug synergy, Co-delivery

4.

Fluorescence Lifetime Nanothermometer Based on the Equilibrium Formation of Anthracene Aie-Excimers in Living Cells

Number of pages: 12 Posted: 10 Apr 2024
Consuelo Ripoll, Almudena del Campo-Balguerías, Carlos Alonso-Moreno, Diego Herrera-Ochoa, Alberto Ocaña, Cristina Martín, Andrés Garzón-Ruíz and Iván Bravo
Universidad de Castilla-La Mancha, affiliation not provided to SSRN, Universidad de Castilla-La Mancha, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Castilla-La Mancha, affiliation not provided to SSRN and Universidad de Castilla-La Mancha
Downloads 38 (1,222,651)

Abstract:

Loading...

Nanothermometer, Aggregation Induced Emission, Living Systems, Breast Cancer, Fluorescence Lifetime Imaging Micros-copy, Anthracene Aggregates

5.

Active Liposomal Targeting for Head and Neck Squamous Cell Carcinoma Treatment

Number of pages: 39 Posted: 06 Mar 2026
Almudena del Campo-Balguerías, Carmen Martín-Hernández, Cristina Herrero-Igartua, Fernando de Andrés, Abdessamad Gueddari, María García-Bravo, Alberto Ocaña, Iván Bravo, Carlos Alonso-Moreno and Corina Lorz
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad de Castilla-La Mancha, University of Castilla-La Mancha, affiliation not provided to SSRN, Hospital Clínico San Carlos-IdISSC, Universidad de Castilla-La Mancha, Universidad de Castilla-La Mancha and affiliation not provided to SSRN
Downloads 35 (1,304,549)

Abstract:

Loading...

head and neck cancer, liposomes, therapy, cisplatin, alpelisib, active targeting